Ovarian cancer is one of the most lethal gynaecological cancers. Its subtle onset and absence of symptoms in early stages are associated with poor prognosis and high mortality. Identification of early biomarkers would aid in ovarian cancer control. Mesenchmal stem cells (MSCs) and/or their secretory products are identified to have cancer inhibitory properties. Therefore, it is of interest to study the anticancer properties of human Wharton's jelly stem cells conditioned medium (hWJSCs-CM) on primary ovarian carcinoma cells in vitro. Primary cultures of epithelial ovarian carcinoma cells (EOCs) and hWJSCs were used in this study. EOCs were exposed to hWJSC-CM (100%) for 24h-72h and changes in mophology and cell proliferation were monitored. Treatment with hWJSC-CM showed altered morphological changes that resulted in death of EOCs. Colorimetric assay [MTT, (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide)] showed mean decreases in EOC proliferation by 16.21%, 23.89% and 40.08% at 24h, 48h and 72h respectively compared to control. Ingenuity Pathway Analysis (IPA, Igenuity Systems, USA) deduced important molecular pathways and signaling networks associated with cancer cell death and these correlated with significant expression of tumour suppresors and apoptotic genes in hWJSCs. Secretory products of hWJSC-CM induced cell death of EOCs via apoptosis. IPA identification of canonical genes/pathways involved in EOCs that overlap with hWJSCs tumour suppressors and apoptosis genes further support this hypotheis. Additional in vitro and in vivo studies are necessary to validate EOCs inhibition with hWJSC-extracts towards their mechanism of action.
Background:
Cancer is a leading cause of death world-wide. The 2012 cancer statistics estimated about 1638,910 new cancer cases and 577,190 cancer related deaths in the United States [1] . Among the cancers in women, ovarian cancer is the most lethal gynaecological cancer and is associated with high mortality [2] . Ovarian cancers arise from the covering surface epithelium of the ovary. The epithelial ovarian cancer (EOC) is classified into five types based on their histopathology and includes high grade serous carcinomas; clear cell carcinomas; endometroid carcinomas; clear cell carcinomas and low-grade serous carcinomas [3] . Its subtle onset and absence of symptoms in early stages are associated with poor prognosis and high mortality. Treatment is effective with better prognosis at early diagnosis. In contrast, failure rates with chemotherapy are high with advanced EOCs and also the mortality. Many factors are involved in the pathogenesis of EOCs. Given the cellular heterogeneity and signaling complexities in EOCs, use of standard chemotherapeutic regimen may not be always successful. This is reflected in the 5 year survival rate which depicts a plateau in the last 15 with slight modifications. Briefly, the samples were washed twice with PBS to remove the blood and tissue debris. The ovarian surface side was placed down on prewarmed Dispase (Sigma, ST Louis, Missouri, USA) and incubated for 30 minutes at 37°C and gently shaked every 10 min. Dispase activity was stopped using RPMI 1640 containing 10% fetal bovine serum (FBS). The contents were transferred to 15 ml conical Falcon tube and centrifuged at 500 g x 5 min. The supernatant was carefully removed and the resuspended cells plated in 100 mm petri dishes (Becton Dickinson, Franklin Lakes, NJ) and cultured using RPMI 1640 media supplemented with 10% FBS, 2mM Glutamax, 1% antibiotics [pencillin (50 IU/ml), streptomycin (50 µg/ml)] at standard culture conditions of 37°C in a 5% CO2 incubator. The cultures were left undisturbed until cell growth was evident, with media changes every 72 h.
Derivation of human Wharton's Jelly stem cells (hWJSCs)
Human umbilical cords were obtained following informed consent from patients undergoing full term derlivery at the Department of Obstetrics and Gynecology, KAUH. The umbilical cord was transfered in a sterile container containing HBSS and antibiotics and processed within 6 h-12 h. Briefly, the umbilical cord was cut into pieces of ~2 cm and opened length wise. The blood vessels were removed and the opened side exposed to an ezyme cocktail containing collagenase Type-I (2 mg/mL), collagenase Type-IV (2 mg/mL) and Hyaluronidase (100 IU) for 30 minutes. The enzyme ativity was blocked by addition of medium containing 10% FBS, and the matrix contents were gently scraped onto the medium The medium containing cells and matrix substance was centrifuged at 500 g x 5 min. The supernatant was discarded and the contents were washed twice with PBS. The resultant pellet was finally resuspended in culture media comprised of DMEM high glucose, supplemented with 10% FBS, 2 mM Glutamax, 1% non-essential aminoacids, basic fibroblast growth factor 16 ng/mL and 1%antibiotics [pencillin (50 IU/ml), streptomycin (50 µg/ml)] and incuabted at standard culture conditions of 37°C in a 5% CO2 incubator. The cultures were left undisturbed until cell growth was evident, with media changes every 72 h. 
hWJSC-Conditioned Media
Derived hWJSCs were grown under standard culture conditions and the media changed every 48 h. When the cells were 70% confluent the culture media was removed and fresh media was added and the cells cultured for upto 72 h. The hWJSC-conditioned media (hWJSC-CM, 100%) was then harvested, filter sterilized using 0.2 µm syringe filters and stored in 4°C as aliquots until further use in experiments.
Cell morpholgy of epithelial ovarian cancer cells (EOCs) cultured in hWJSC-CM
EOCs were plated at a seeding density of 2x10 4 cells/well of a 24 well plate and allowed to attach overnight. The media was removed and hWJSC-CM (100%) was added to the experimental wells, while the controls were maintained in standard culture media. Both controls and experimental groups were cultured at 37°C in a 5% CO2 incubator for up to 72 h. Cell morphology were imaged every 24 h using phase contrast microscopy. 
Proliferation of epithelial ovarian cancer cells (EOCs

Ingenuity pathway analysis
Functional core analysis to predict networks that are invovled in EOCs were performed using Ingenuity Pathway analysis (IPA) software, (Ingenuity Systems, USA). Details of the genes invovled in EOC [Janus kinase 2 (JAK2), Kirsten rat sarcoma viral oncogene homolo (KRAS), v-myc avian myelocytomatosis viral oncogene homolog (MYC), phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA), B-cell CLL/lymphoma 2 (BCL2), tumor protein p53 (TP53) and phosphatase and tensin homolog (PTEN), cyclin-dependent kinase inhibitor 2A (CDKN2A), ATM serine/threonine kinase (ATM)] were imported into the IPA software to predict signaling mechanisms, targets and their association to genes expressed by hWJSCs. Network predictions based on gene input were generated using algorithms contained in Ingenuity Knowledge Base. Fischer's Exact test was done to calculate the p-value indicating the probability of each biological function associated with the network. 
Results: Primary cultures of EOCs and hWJSCs
Morphological changes of EOCs exposed to hWJSC-CM
The EOCs exposed to hWJSC-CM (100%) demonstrated varying changes in morphology including decrease in size and fragmentation of cells leading to cell death (Figure 2A-D) . The cells appeared thin and elongated and had lost their characteristic epitheloid shape in cultures. There was also a decrease in cell numbers in the treated group compared to controls at 24 h, 48 h and 72 h (Figure 2A-D) .
Proliferation EOCs exposed to hWJSC-CM EOCs exposed to hWJSC-CM (100%) showed time dependent decrease in cell proliferation at 24 h, 48 h and 72 h compared to the untreated controls (Figure 3) . The mean decreases observed in EOCs were 16.21%, 23.89% and 40.08% for 24 h, 48 h and 72 h respectively compared to the untreated control. These decreases in cell proliferation were statistically significant (p < 0.05) compared to the control. In the present study too we identified that hWJSC-CM inhibit the primary epithelial ovaian cancer cells (EOCs, Figure 3) . As there were no direct contact of the stem cells (hWJSCs) with EOCs, any inhibitory action observed is probably due to the factors secreted by hWJSCs into the medium. Earlier transcriptome studies on hWJSCs have identifed increased expression of tumour suppressor genes and apoptosis inducing genes [21] . There were significant overlap in the canonical pathways and molecular mechanisms in EOCs as identified by IPA with that of the transcriptome profile of hWJSCs indicating that hWJSCs might be targeting these pathways to bring about caner cell inhibition ( Figure 4B) . Furhter protemoics studies of hWJSC-CM is however necessary to help identification of the putative molecule(s) that bring about cancer cell death.
Ingenuity pathways analysis of EOC genes
Conclusions:
Results show that hWJSC-CM induce inhibition of primary EOCs in vitro and cause cell death. The IPA predictive results indicating the genes/targets involved in EOCs that overlap wtih hWJSCs tumour suppressors further support this hypotheis. Additional in vitro and in vivo studies are necessary to validate EOCs inhibition with hWJSC-extracts to identify putative molecules/targets of cancer inhibition.
